Summary

News Dishman Carbogen Amcis Ltd has been named one of the Best Indian Investment in France for a specific period by the Indo French Chamber of Commerce. In a significant ceremony held in New Delhi in 2024, the company received the prestigious Choose France Best Indian Investment award alongside Business France India as a partner at one of the major Indo-French Business Awards. The company celebrated these accolades by successfully executing a clinical research study that addressed vitamin D deficiency in patients suffering from COVID-19 in Ahmedabad, demonstrating a positive response in patients with COVID-19 and improved immune function. This success highlights Amcis Ltd's role as a global outsourcing partner dedicated to advancing pharmaceuticals for international markets. The partnership with Boston University School of Medicine involved significant collaboration to investigate the efficacy of oral 25-Hydroxyvitamin D3, which proved effective for correcting vitamin D deficiency in patients with COVID-19. The achievement underscores Amcis Ltd's capability to lead international collaborations and drive innovation in healthcare technology across diverse regions and healthcare sectors.

Title

Dishman Carbogen Amcis Ltd

Description

Dishman Carbogen Amcis Ltd is a global outsourcing partner for the pharmaceutical industry, offering contract research, development, and manufacturing services. Specialising in APIs and high-potency compounds, it delivers innovative, high-quality healthca

Keywords

services, pharmaceutical, manufacturing, capabilities, development, inspection, republic, news, india, company, france, products, health, vitamin, apis, industry, facility

NS Lookup

A 159.69.61.90

Dates

Created 2026-03-07

Updated 2026-04-14

Summarized 2026-04-14